3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Graft vs Host Disease
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
39
fludarabine phosphate
37
Azacitidine
33
fludarabine
25
Whole-Body Irradiation
22
Busulfan
22
Tacrolimus
21
Antilymphocyte Serum
21
Mycophenolic Acid
19
Filgrastim
18
Methotrexate
16
Melphalan
15
venetoclax
13
Peripheral Blood Stem Cell Transplantation
13
Granulocyte Colony-Stimulating Factor
13
Cytarabine
13
thymoglobulin
12
Cyclosporine
12
Thiotepa
9
Cord Blood Stem Cell Transplantation
9
Alemtuzumab
8
Rituximab
7
Radiotherapy
7
Methylprednisolone
7
Decitabine
7
Clofarabine
7
Lenalidomide
6
Stem Cell Transplantation
5
Sirolimus
5
Nivolumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Myelodysplastic Syndromes
×
Calcineurin Inhibitors
×
Clear all
NCT01749111
2017-03-03
CICLODECH
Hospital Israelita Albert Einstein
Phase 3
Terminated
3 enrolled